Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: an evidence-based review from the Cancer Genomics …
TJ Pugh, JM Fink, X Lu, S Mathew, J Murata-Collins… - Cancer genetics, 2018 - Elsevier
Abstract Background Plasma cell neoplasms (PCNs) encompass a spectrum of disorders
including monoclonal gammopathy of undetermined significance, smoldering myeloma …
including monoclonal gammopathy of undetermined significance, smoldering myeloma …
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics …
TJ Pugh, JM Fink, X Lu, S Mathew… - Cancer …, 2018 - cancergeneticsjournal.org
Abstract Background Plasma cell neoplasms (PCNs) encompass a spectrum of disorders
including monoclonal gammopathy of undetermined significance, smoldering myeloma …
including monoclonal gammopathy of undetermined significance, smoldering myeloma …
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics …
TJ Pugh, JM Fink, X Lu, S Mathew… - Cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Plasma cell neoplasms (PCNs) encompass a spectrum of disorders including
monoclonal gammopathy of undetermined significance, smoldering myeloma, plasma cell …
monoclonal gammopathy of undetermined significance, smoldering myeloma, plasma cell …
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics …
Cancer Genomics Consortium Plasma … - Cancer …, 2018 - scholars.northwestern.edu
Background: Plasma cell neoplasms (PCNs) encompass a spectrum of disorders including
monoclonal gammopathy of undetermined significance, smoldering myeloma, plasma cell …
monoclonal gammopathy of undetermined significance, smoldering myeloma, plasma cell …
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics …
TJ Pugh, JM Fink, X Lu, S Mathew… - Cancer …, 2018 - europepmc.org
Background Plasma cell neoplasms (PCNs) encompass a spectrum of disorders including
monoclonal gammopathy of undetermined significance, smoldering myeloma, plasma cell …
monoclonal gammopathy of undetermined significance, smoldering myeloma, plasma cell …
[PDF][PDF] Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer …
TJ Pugh, JM Fink, X Lu, S Mathew, J Murata-Collins… - Cancer, 2018 - cancergenomics.org
Abstract Background: Plasma cell neoplasms (PCNs) encompass a spectrum of disorders
including monoclonal gammopathy of undetermined significance, smoldering myeloma …
including monoclonal gammopathy of undetermined significance, smoldering myeloma …